Sildenafil Citrate Tablet, Film Coated
Product Images NDC 82804-025

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 82804-025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Sildenafil_fig1.jpg (Sildenafil Fig1)

Line graph showing the mean change from baseline in sitting systolic blood pressure over 24 hours in healthy volunteers after dosing with Sildenafil 100 mg and placebo. The x-axis represents time post dose in hours, and the y-axis represents systolic blood pressure change in mmHg. The graph includes data points for pre-dose and multiple post-dose times up to 24 hours.*

FDA Label Image

Sildenafil_fig3 (Sildenafil Fig 3)

A line chart showing mean standing systolic blood pressure changes from baseline over time (hours) postdose. It compares two groups: one receiving Doxazosin plus placebo and the other Doxazosin plus Sildenafil 50 mg, with measurements plotted across an 8-hour period.*

FDA Label Image

Sildenafil_fig_4 (Sildenafil Fig 4)

A line graph titled 'Mean Standing Systolic Blood Pressure Change from Baseline' comparing changes over 8 hours between two groups: Doxazosin plus Sildenafil 100 mg and Doxazosin plus Placebo. The y-axis shows blood pressure change in mmHg, ranging from -50 to 40, and the x-axis shows time after dosing in hours from 0 to 8. Data points indicate that systolic blood pressure decreases shortly after dosing and then stabilizes for both groups.*

FDA Label Image

Sidenafil_fig_5 (Sildenafil Fig 5)

A line chart illustrating mean plasma concentrations of Sildenafil over 24 hours in healthy male volunteers after administration of a commercial tablet. The x-axis represents time post dose in hours, and the y-axis shows plasma concentration in ng/ml. Concentrations peak sharply within the first few hours and then gradually decline.*

FDA Label Image

82804-025-90 (Sildenafil 100mg)

Sildenafil Citrate 100 mg film-coated tablets label from Proficient Rx LP. The label indicates a bottle of 90 tablets, with each green, oval-shaped, beveled edge, biconvex, film-coated tablet imprinted with "100" on the obverse side and "SC" on the reverse. Marketed by Ajanta Pharma USA Inc., the label includes NDC 82804-025-90 and storage instructions at 25°C (77°F).*

FDA Label Image

Sildenafil-fig7 (Sildenafil Fig7)

A bar chart showing the percentage of patients reporting improvement across four treatment groups: placebo, sildenafil tablets 25 mg, sildenafil tablets 50 mg, and sildenafil tablets 100 mg. The percentage of improvement increases with dosage, from 24% for placebo up to 82% for the 100 mg sildenafil tablets.*

FDA Label Image

Str (Sildenafil Structure)

Chemical structure of Sildenafil, the active ingredient in Sildenafil Citrate 100 mg oral film-coated tablets by Proficient Rx LP. The diagram shows the molecular arrangement used to represent this prescription drug's chemical composition.*

FDA Label Image

Figure2 (Sildenafil Fig2)

A line chart depicting the change in EDP (mmHg) over time postdose (hours) comparing Doxazosin + Placebo versus Doxazosin + Sildenafil 25 mg. The x-axis shows time in hours from 0 to 8, and the y-axis shows change in EDP in mmHg ranging from -40 to 20.*

FDA Label Image

Sildenafil_fig6b (Sildenafil Fig6b)

A bar chart showing the distribution of patients at endpoint based on baseline scores from 0 to 5. The vertical axis represents the percentage of patients, while the horizontal axis shows baseline score categories. Multiple bars per category indicate different groups or conditions compared in the chart.*

FDA Label Image

Sildenafil_fig6a (Sildenafil Figure6a)

A bar graph depicting the percentage of patients at the endpoint categorized by baseline score. The x-axis represents baseline scores from 0 to 5, and the y-axis shows the percentage of patients. Multiple bar series are displayed for each baseline score, indicating different groups or categories of patient percentages.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.